Organometallic Ligands

R 112 is a chlorinated fluorocarbon compound, which is an industrial chemical synthesized through halogenation processes typically involving methane or ethane derivatives. The mode of action of R 112 involves its utilization as a refrigerant, solvent, or chemical intermediate, leveraging its stability and volatility under various thermal conditions.

11-Pentafluorophenoxyundecyltriethoxysilane is an organosilane compound, which is a specialized reagent for creating functional coatings. This compound is synthesized from phenol derivatives through the substitution of ethoxy groups, allowing it to integrate with various surfaces. Its mode of action involves hydrolysis of the triethoxy groups to form silanols, which can then covalently bond with hydroxyl groups present on substrates such as glass, metals, and silica.

SHIN 1New is an advanced therapeutic compound, originating from synthetic chemical processes, designed for intricate bioactivity modulation. It operates through a selective mechanism of action that targets and modulates specific molecular pathways, allowing scientists to investigate biological processes with high precision. This compound is utilized primarily in pharmaceutical research and development, where it serves as a critical tool for understanding the pathways and molecular interactions implicated in disease mechanisms. The precision and specificity it offers make it invaluable for experimental therapeutics, and its applications extend to drug discovery and the development of personalized medicine approaches. SHIN 1New's unique attributes allow for enhanced interaction studies within cellular environments, facilitating breakthroughs in the comprehension and manipulation of complex biological systems.

Bis-imidazole phenol IDH1 inhibitor is a small-molecule therapeutic, which is a novel compound synthesized to specifically target mutant forms of isocitrate dehydrogenase 1 (IDH1). It operates by binding to the mutant IDH1 enzyme and inhibiting its aberrant function, which involves converting alpha-ketoglutarate to an oncometabolite, 2-hydroxyglutarate (2-HG). This conversion leads to epigenetic changes that drive the tumorigenesis process.

PKI (5-24) is a synthetic peptide specifically designed as a protein kinase inhibitor. Derived from a segment of the endogenous PKA inhibitor protein, this peptide is utilized to inhibit the activity of cyclic AMP-dependent protein kinase (PKA). The sequence corresponds to amino acids 5-24 of the native protein, retaining its potent inhibitory activity. PKI (5-24) functions by binding to the catalytic subunit of PKA, thus preventing the phosphorylation of downstream targets.

Acat-in-1 cis isomer is an enzymatic inhibitor, which is synthesized through organic chemical processes. It is particularly known for its action as an inhibitor of acyl-coenzyme A:cholesterol acyltransferase (ACAT), an enzyme crucial for the esterification of cholesterol. This inhibition occurs through the specific binding to the active site of ACAT, preventing the conversion of cholesterol to cholesteryl esters, and thereby influencing the cholesterol metabolism pathways.

XL413 hydrochloride is a potent small-molecule inhibitor, which is a synthetic compound specifically designed to target protein kinases. It acts as a selective inhibitor of Cdc7 kinase, a serine/threonine kinase essential for the initiation of DNA replication. This kinase is involved in the phosphorylation of MCM2 and the activation of the pre-replicative complex, a critical step in the S-phase of the cell cycle. By inhibiting Cdc7, XL413 hydrochloride effectively halts cell cycle progression, thereby impacting cellular proliferation.

CPI-455 HCl is a potent, selective bromodomain inhibitor, which is a synthetic chemical compound designed to modulate epigenetic targets. Its source is a laboratory-synthesized small molecule developed to specifically inhibit the activity of bromodomains, which are protein domains that recognize acetylated lysine residues. The mode of action involves competitively binding to bromodomains, thereby preventing the interaction between these domains and acetylated histones. This inhibition disrupts the transcriptional activity of bromodomain-containing proteins and can alter gene expression patterns.

AT-9283 L-lactate is a potent small-molecule inhibitor, which is derived from synthetic sources and designed to target specific protein kinases involved in critical signaling pathways. As a multi-targeted kinase inhibitor, it has a particular affinity for the JAK2, JAK3, Aurora A, and Aurora B kinases, acting to disrupt the JAK/STAT pathway alongside other crucial cellular processes. The specificity and potency of AT-9283 L-lactate allow it to modulate these pathways effectively by preventing phosphorylation events that are essential for cellular proliferation and survival.

MPI-0479605 is a small molecule inhibitor, specifically designed to target and inhibit the activity of certain protein kinases. It is synthetically derived and formulated to interact with key signaling pathways involved in cellular growth and proliferation. The compound works by selectively binding to the ATP-binding site of the targeted kinases, thereby preventing their phosphorylation activity. This interaction disrupts downstream signaling pathways, ultimately influencing cellular functions such as differentiation, apoptosis, and migration.

N-(2-Chloro-6-methylphenyl)-N'-4-pyridinylurea is a systemic herbicide, which is synthesized from chloro- and methyl-substituted phenyl compounds. It exhibits its mode of action by inhibiting the photosystem II complex, thereby disrupting the electron transport chain during photosynthesis in susceptible plants. This leads to a decline in ATP and NADPH production, essential for plant growth and survival.

BMS-1166 is a small molecule immunotherapy agent that functions as a PD-1 antagonist. It is derived from targeted drug design, focusing on disrupting the interaction between the programmed cell death protein 1 (PD-1) and its ligands, PD-L1 and PD-L2.

LY 266097 Hydrochloride is a selective 5-HT2A receptor antagonist, which is a synthetic compound primarily used in neuroscience research. This compound is derived from laboratory synthesis, designed to interact specifically with serotonin receptors located in the central nervous system.

Please enquire for more information about KYT 0353 including the price, delivery time and more detailed product information at the technical inquiry form on this page

Cardanol monoene is a phenolic lipid, which is a natural derivative obtained from cashew nut shell liquid. It is sourced from the renewable agricultural by-product of the Anacardium occidentale, allowing for a sustainable means of production. Its chemical structure features a phenolic ring with an aliphatic chain, which imparts unique properties that facilitate its mode of action.

Bio-013077-01 is a bioactive compound, which is a naturally derived product sourced from marine organisms. Its mode of action involves functioning as an enzyme inhibitor, capable of selectively binding to specific target enzymes and altering their activity. This mechanism allows it to modulate biochemical pathways that are crucial for various physiological and pathological processes.

Pglu-Pro-Arg-mna monoacetate is a synthetic peptide inhibitor, which is typically derived from biochemical synthesis processes involving solid-phase peptide synthesis. Its primary mode of action is the competitive inhibition of certain enzyme activities, commonly within the realm of proteolytic enzymes. By mimicking substrate structures, it effectively binds to the enzyme's active site, thereby preventing the actual substrate from interacting and consequently inhibiting the enzyme's activity.

BOP is a coupling reagent, which is derived from phosphonium sources and employed in peptide synthesis. It functions by facilitating the formation of peptide bonds between amino acids through its highly effective activation mechanism. BOP acts as an agent that promotes the formation of amide bonds, crucial in the construction of polypeptide chains.

SB-242084 hydrochloride is a selective antagonist of 5-HT2C receptors, which is a synthetic compound developed to study serotonergic pathways in neuroscience research. This compound originates from pharmaceutical research efforts to explore new avenues for modulating serotonin receptor subtypes, offering specificity for 5-HT2C receptors with minimal activity against 5-HT2A and 5-HT2B receptors.

BP 554 maleate is a synthetic compound, specifically a chemical analog, which is primarily derived through laboratory synthesis processes. It functions as a potential antihypertensive agent by acting on specific biochemical pathways to modulate vascular tone. The mode of action involves interfering with receptor sites or enzymatic pathways, which subsequently results in the relaxing of vascular smooth muscles and a decrease in peripheral vascular resistance. This compound has been studied for its utility in managing conditions related to elevated blood pressure and might offer insights into novel therapeutic approaches for cardiovascular disease management. As such, BP 554 maleate serves as a valuable tool in pharmacological research, particularly in the exploration of cardiovascular therapeutics and the development of new drug formulations aimed at optimizing blood pressure control.